BeStock  
Stocks › VRDN

Viridian Therapeutics VRDN

US equityMarket cap rank #2720
$19.00 −$0.40 (-2.06%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $19.00 0.00%
Open$19.41
Prev close$19.40
Day range$18.83 – $19.59
Volume2.65M
Market cap$2.15B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±9.9%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+49.4%
Worst reaction-17.2%

Stock move on the day after each report

+0.5%2019/Q3-16.7%2019/Q4+7.3%2020/Q1-6.8%2020/Q2+4.7%2020/Q4+5.5%2021/Q4+28.0%2022/Q1+49.4%2022/Q2-0.9%2022/Q3-10.5%2022/Q4-1.2%2023/Q1-1.6%2024/Q1
QuarterReport dateTimingImplied moveActual moveVersus implied
2024/Q18 May 2024Pre Market±13.1%-1.59%Within range
2023/Q19 May 2023After Market±22.8%-1.21%Within range
2022/Q48 Mar 2023Pre Market±15.9%-10.48%Within range
2022/Q314 Nov 2022Pre Market±19.9%-0.93%Within range
2022/Q215 Aug 2022Pre Market–+49.36%–
2022/Q112 May 2022None±11.4%+28.03%Bigger than priced
2021/Q410 Mar 2022None±23.6%+5.46%Within range
2020/Q425 Mar 2021After Market–+4.75%–
2020/Q25 Aug 2020None–-6.84%–
2020/Q17 May 2020None–+7.27%–
2019/Q411 Mar 2020After Market–-16.65%–
2019/Q37 Nov 2019After Market–+0.55%–
2019/Q27 Aug 2019After Market–-17.20%–
2019/Q18 May 2019After Market–+0.00%–
2018/Q413 Mar 2019After Market–+2.64%–
2018/Q37 Nov 2018After Market–-5.26%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q1

By business line

  • Collaboration revenue - related parties$135,000.00 95.7%
  • Discovering, developing and commercializing potential best-in-class medicines for serious and rare$6,000.00 4.3%

Discussion

No comments yet — be the first to weigh in on VRDN.

Leave a comment

Scroll to Top